Article

AMO acquires IntraLase

The acquisition of IntraLase Corp. by Advanced Medical Optics (AMO), announced Jan. 9, joins two of the strongest performers in the refractive surgery market. The $808 million cash transaction may be the impetus for a change in how the traditional microkeratome is viewed among refractive surgeons.

Related Videos
Image credit: Ophthalmology Times; EnVision Summit 2025: Sonia H. Yoo, MD, shares what to expect from the cataract and refractive agenda
Ophthalmology Times: Kathryn Colby, MD, PhD, reflects on National Women Physicians Day
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.